Kaiqi Du

874 total citations
35 papers, 438 citations indexed

About

Kaiqi Du is a scholar working on Pulmonary and Respiratory Medicine, Oncology and Molecular Biology. According to data from OpenAlex, Kaiqi Du has authored 35 papers receiving a total of 438 indexed citations (citations by other indexed papers that have themselves been cited), including 28 papers in Pulmonary and Respiratory Medicine, 18 papers in Oncology and 9 papers in Molecular Biology. Recurrent topics in Kaiqi Du's work include Lung Cancer Treatments and Mutations (23 papers), Lung Cancer Research Studies (11 papers) and Cancer Genomics and Diagnostics (6 papers). Kaiqi Du is often cited by papers focused on Lung Cancer Treatments and Mutations (23 papers), Lung Cancer Research Studies (11 papers) and Cancer Genomics and Diagnostics (6 papers). Kaiqi Du collaborates with scholars based in China, Belgium and United States. Kaiqi Du's co-authors include You‐cai Zhu, C. Xu, Wenxian Wang, Guojun Chen, Taifeng Liu, Wu Zhuang, Huafei Chen, Yong Song, Tangfeng Lv and Lixin Wu and has published in prestigious journals such as Journal of Clinical Oncology, Biochemical and Biophysical Research Communications and International Journal of Molecular Sciences.

In The Last Decade

Kaiqi Du

35 papers receiving 437 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Kaiqi Du China 14 274 227 162 100 30 35 438
Yalun Li China 12 163 0.6× 164 0.7× 117 0.7× 89 0.9× 25 0.8× 39 412
Amanda C. Pawlak United States 4 423 1.5× 339 1.5× 180 1.1× 144 1.4× 30 1.0× 5 576
Y. Ko Germany 6 185 0.7× 221 1.0× 117 0.7× 67 0.7× 35 1.2× 13 490
Hongtao Luo China 9 140 0.5× 119 0.5× 118 0.7× 71 0.7× 35 1.2× 54 333
Anna Johnson United States 14 244 0.9× 95 0.4× 165 1.0× 90 0.9× 16 0.5× 38 408
Laure Hirsch France 9 246 0.9× 297 1.3× 183 1.1× 116 1.2× 24 0.8× 16 517
H. Bülzebruck Germany 10 263 1.0× 200 0.9× 67 0.4× 53 0.5× 18 0.6× 23 400
Matteo Perrino Italy 15 372 1.4× 166 0.7× 137 0.8× 60 0.6× 37 1.2× 48 670
Begoña Pérez‐Valderrama Spain 13 220 0.8× 148 0.7× 155 1.0× 106 1.1× 23 0.8× 50 405
Enas Alawi United States 3 281 1.0× 251 1.1× 182 1.1× 90 0.9× 8 0.3× 4 430

Countries citing papers authored by Kaiqi Du

Since Specialization
Citations

This map shows the geographic impact of Kaiqi Du's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kaiqi Du with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kaiqi Du more than expected).

Fields of papers citing papers by Kaiqi Du

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Kaiqi Du. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kaiqi Du. The network helps show where Kaiqi Du may publish in the future.

Co-authorship network of co-authors of Kaiqi Du

This figure shows the co-authorship network connecting the top 25 collaborators of Kaiqi Du. A scholar is included among the top collaborators of Kaiqi Du based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Kaiqi Du. Kaiqi Du is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Huang, Jianxi, Zhuo Wen, Hai Huang, et al.. (2025). Progress and Perspectives of Crop Yield Forecasting With Remote Sensing: A review. IEEE Geoscience and Remote Sensing Magazine. 13(3). 338–368. 3 indexed citations
2.
Du, Kaiqi, Shuangxi Miao, Xuecao Li, et al.. (2025). Improved Soybean Mapping with Spectral Gaussian Mixture Modeling. Lirias (KU Leuven). 5. 1 indexed citations
3.
Huang, Jianxi, Jianjian Song, Xuecao Li, et al.. (2024). A novel soybean mapping index within the global optimal time window. ISPRS Journal of Photogrammetry and Remote Sensing. 217. 120–133. 3 indexed citations
4.
Chen, Huafei, Wenxian Wang, Xiaofeng Li, et al.. (2020). Eye metastasis in lung adenocarcinoma mimicking anterior scleritis: A case report. World Journal of Clinical Cases. 8(2). 410–414. 5 indexed citations
5.
Chen, Huafei, Wenxian Wang, C. Xu, et al.. (2020). A novel SOS1-ALK fusion variant in a patient with metastatic lung adenocarcinoma and a remarkable response to crizotinib. Lung Cancer. 142. 59–62. 11 indexed citations
6.
Wu, Lixin, Lei Lei, You‐cai Zhu, et al.. (2020). A prostate cancer patient with isolated lung metastases: a case report. Translational Cancer Research. 9(3). 2064–2068. 10 indexed citations
7.
Zhu, You‐cai, Wenxian Wang, C. Xu, et al.. (2019). A Patient With Lung Adenocarcinoma With BRAF Gene Fusion and Response to Vemurafenib. Clinical Lung Cancer. 20(3). e224–e228. 9 indexed citations
8.
Chen, Huafei, Lei Lei, Lixin Wu, et al.. (2019). Effect of icotinib on advanced lung adenocarcinoma patients with sensitive EGFR mutation detected in ctDNA by ddPCR. Translational Cancer Research. 8(8). 2858–2863. 5 indexed citations
9.
Zhu, You‐cai, Xueping Lin, Wenxian Wang, et al.. (2019). Clinicopathological features and clinical efficacy of crizotinib in Chinese patients with ROS1‑positive non‑small cell lung cancer. Oncology Letters. 17(3). 3466–3474. 13 indexed citations
10.
Chen, Huafei, You‐cai Zhu, Kaiqi Du, et al.. (2018). Intestinal metastasis from primary<em> ROS1</em>-positive lung adenocarcinoma cancer patients responding to crizotinib. OncoTargets and Therapy. Volume 11. 7821–7825. 3 indexed citations
11.
Zhu, You‐cai, Wenxian Wang, C. Xu, et al.. (2018). Lung adenocarcinoma patient with an EGFR kinase domain duplication (KDD) and the response to icotinib. Journal of Thoracic Disease. 10(5). E359–E363. 13 indexed citations
12.
Zhu, You‐cai, Wenxian Wang, C. Xu, et al.. (2018). The KIF5B-RET Fusion Gene Mutation as a Novel Mechanism of Acquired EGFR Tyrosine Kinase Inhibitor Resistance in Lung Adenocarcinoma. Clinical Lung Cancer. 20(1). e73–e76. 14 indexed citations
13.
Zhu, You‐cai, Wenxian Wang, C. Xu, et al.. (2017). Dual drive coexistence of EML4‐ALK and TPM3‐ROS1 fusion in advanced lung adenocarcinoma. Thoracic Cancer. 9(2). 324–327. 9 indexed citations
14.
Zhu, You‐cai, Wenxian Wang, C. Xu, et al.. (2017). Patients harboring <em>ALK </em>rearrangement adenocarcinoma after acquired resistance to crizotinib and transformation to small-cell lung cancer: a case report. OncoTargets and Therapy. Volume 10. 3187–3192. 27 indexed citations
15.
Zhu, You‐cai, Wenxian Wang, C. Xu, et al.. (2017). EGFR-RAD51 fusion variant in lung adenocarcinoma and response to erlotinib: A case report. Lung Cancer. 115. 131–134. 20 indexed citations
16.
17.
Xu, C., et al.. (2016). Lung cancer with concurrent <em>EGFR</em> mutation and <em>ROS1</em> rearrangement: a case report and review of the literature. OncoTargets and Therapy. Volume 9. 4301–4305. 20 indexed citations
18.
Zhi, Xiuyi, Etienne Giroux‐Leprieur, Marie Wislez, et al.. (2015). Human RNA polymerase II associated factor 1 complex promotes tumorigenesis by activating c-MYC transcription in non-small cell lung cancer. Biochemical and Biophysical Research Communications. 465(4). 685–690. 18 indexed citations
19.
Moubayidin, Laila, Kaiqi Du, Alessandra Boccaccini, et al.. (2015). The COP9 SIGNALOSOME Is Required for Postembryonic Meristem Maintenance in Arabidopsis thaliana. Molecular Plant. 8(11). 1623–1634. 16 indexed citations
20.
Du, Kaiqi, et al.. (2013). Platelet count predicts prognosis in operable non-small cell lung cancer. Experimental and Therapeutic Medicine. 5(5). 1351–1354. 40 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Yalun Li Breakdown of academic impact, for papers by Amanda C. Pawlak Breakdown of academic impact, for papers by Y. Ko Breakdown of academic impact, for papers by Hongtao Luo Breakdown of academic impact, for papers by Anna Johnson Breakdown of academic impact, for papers by Laure Hirsch Breakdown of academic impact, for papers by H. Bülzebruck Breakdown of academic impact, for papers by Matteo Perrino Breakdown of academic impact, for papers by Begoña Pérez‐Valderrama Breakdown of academic impact, for papers by Enas Alawi
Rankless by CCL
2026